Table 4.
Effect | Odds ratio | 95% Wald confidence limits | P value | |
---|---|---|---|---|
Age* | 1.02 | 1.00 | 1.03 | 0.04 |
Gender (female)* | 1.95 | 1.44 | 2.64 | <.0001 |
BMI ≥30* | 1.34 | 0.89 | 2.02 | 0.16 |
Race-risk* | 0.42 | 0.21 | 0.83 | 0.01 |
Income (family income <$40K)* | 0.72 | 0.49 | 1.06 | 0.10 |
Smoking (current)* | 0.87 | 0.59 | 1.29 | 0.49 |
Medications (mean number)* | 0.95 | 0.93 | 0.98 | <0.001 |
Depression* | 0.57 | 0.36 | 0.88 | 0.01 |
Dyslipidemia* | 0.66 | 0.46 | 0.94 | 0.02 |
Sulfonylureas (SU) † | 0.40 | 0.29 | 0.55 | <0.001 |
Metformin† | 1.51 | 0.36 | 6.34 | 0.58 |
SU + Metformin† | 0.27 | 0.15 | 0.48 | <0.001 |
Nutrition visits (any)† | 1.90 | 1.33 | 2.72 | <0.001 |
Quit smoking† | 0.67 | 0.26 | 1.72 | 0.40 |
HbA1c‡ mean† | 0.56 | 0.49 | 0.65 | <0.001 |
*These characteristics were assessed at baseline; BMI = body mass index
†These characteristics were assessed during the trajectory
‡HbA1c = Hemoglobin A1c